A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers
Status:
Not yet recruiting
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
The study is a single-center, open, single-dose, self-controlled clinical trial. It is
planned to enroll 20 healthy adult subjects.Subjects will take the SHR6390 on Day1 and Day22
, and from Day8 to Day26 take the efavirenz.